Agilent Technologies provides bio-analytical solutions and services to the life sciences, diagnostics and genomics, chemical analysis, communications, and electronics industries worldwide. The company was founded in 1999 and is based in Santa Clara, California.
A Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for Agilent Technologies Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Agilent Technologies Inc ranked in the 25th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Agilent Technologies Inc, consider:
The company has produced more trailing twelve month cash flow than 74.94% of its sector Healthcare.
The business' balance sheet suggests that 6% of the company's capital is sourced from debt; this is greater than just 17.82% of the free cash flow producing stocks we're observing.
A's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 41.59% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as A, try ILMN, SNN, ABC, LGND, and RMD.
A report by The Insight Partner's on the Immunohistochemistry Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in the market
The motive of this strategic research report entitled Global Pharmaceutical Packaging Market Which offers company accounts, industry investors, and industry members with consequential insights to enable them to make reliable strategic decisions regarding the opportunities in the global Pharmaceutical Packaging
According to the new market research report "Immunohistochemistry/IHC Market by Product (Antibodies, Reagents (Chromogenic Substrates), Kits), Application (Diagnostics (Cancer, Infectious), Research, Forensic), End User (Hospitals, Diagnostic Laboratories, Academic) - Global Forecast to 2025", published by MarketsandMarkets™, analyzes and studies the
The Business Research Company offers "Gene Editing Global Market Report 2020-30: COVID-19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it